<?xml version="1.0" encoding="UTF-8"?>
<p id="p0045">An expert opinion on the potential for repurposing existing antiviral agents to treat COVID-19, some of which are already clinically evaluated, was recently given.
 <xref rid="bib5" ref-type="bibr">
  <sup>5</sup>
 </xref> Here, we discuss molecular targets of the SARS-CoV-2, some of the known small molecules, and the potential for repurposing existing drugs.
</p>
